InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,828.00
(
0.95%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
86.78
(
0.00%
)
Bitcoin
57,456.73
(
-1.45%
)
Post# of 23979
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

BioSpecialist

Send PM Follow Ignore
Followers 128
Posts 2150
Boards Moderated 1
Alias Born 12/27/2007

BioSpecialist

Re: None

Wednesday, 06/04/2014 8:40:23 AM

Wednesday, June 04, 2014 8:40:23 AM

Post# of 23979


ADCOM on July 30 ...I think EDAP has the potential to run 50-100% just before ADCOM and could hit $8-10 on positive outcome .US approval would drive EDAP deep into Profitability .

EDAP

Marktet Cap: $81 M
Cash: $18 M

Shares Out: 24.8 M


EDAP's Ablatherm-HIFU FDA Panel Meeting Confirmed for July 30, 2014
http://finance.yahoo.com/news/edaps-ablatherm-hifu-fda-panel-123000701.html


http://www.cancerfactorfiction.com/prostate-cancer/hifu-success-rates/

http://www.hifu.ca HIFU has high success rates with the 700 patients treated at the Maple Leaf HIFU clinic. Over 300,000 patients have been treated worldwide by HIFU, with 10 years of documented success for treating prostate cancer with Ablatherm HIFU – High Intensity Focused Ultrasound.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up